Skip to the page

Data / Drug companies / Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries, Inc.: 239 products in the FDA NDC directory, labeler code 62756

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Sun Pharmaceutical Industries, Inc. (labeler code 62756) lists 239 products in the FDA National Drug Code Directory, covering 44 finished drugs by generic name. By type: 146 bulk ingredients, 87 prescription drugs. Its main marketing category is bulk ingredients. The newest product started marketing on July 28, 2026.

The request: Watch Sun Pharmaceutical Industries, Inc. (FDA labeler code 62756): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
62756
Products in commercial distribution
239
Packages
422
Finished drugs by generic name
44
Prescription products
87
Over the counter products
5
Controlled substance products
Schedule III 11, Schedule IV 5, Schedule V 2
Flagged as original packager
91 of 91 products that carry the flag
Started marketing in the last 12 months
14
Products with a marketing end date set
1
Earliest marketing start
February 9, 2006
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients14661.1%
Generic drugs (ANDA)9037.7%
New drug applications (NDA)20.8%
Drugs for further processing10.4%

Products by type

TypeProductsShare
Bulk ingredients14661.1%
Prescription drugs8736.4%
Over the counter drugs52.1%
Drugs for further processing10.4%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Powder14661.1%
Tablet, film coated208.4%
Tablet187.5%
Capsule156.3%
Injection, solution93.8%
Tablet, delayed release41.7%
Tablet, extended release41.7%
Injection, powder, lyophilized, for solution31.3%
Tablet, for suspension31.3%
Injectable, liposomal20.8%
Tablet, orally disintegrating20.8%
Suspension/ drops20.8%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Sugammadex62756-079Injection, solutionGeneric drugs (ANDA)July 28, 2026
Orlistat62756-047PowderBulk ingredientsJuly 8, 2026
Liothyronine sodium62756-447PowderBulk ingredientsJune 10, 2026
Paliperidone palmitate62756-934PowderBulk ingredientsApril 17, 2026
Divalproex sodium process-ii62756-932PowderBulk ingredientsFebruary 17, 2026
Teriparatide62756-715PowderBulk ingredientsDecember 30, 2025
Lanreotide acetate62756-929PowderBulk ingredientsDecember 10, 2025
Liraglutide62756-927PowderBulk ingredientsDecember 10, 2025
Bosutinib62756-721PowderBulk ingredientsDecember 10, 2025
Alectinib hydrochloride62756-704PowderBulk ingredientsDecember 10, 2025
Dasatinib62756-703PowderBulk ingredientsDecember 10, 2025
Afatinib dimaleate62756-050PowderBulk ingredientsDecember 10, 2025
Colestipol hydrochloride62756-930PowderBulk ingredientsNovember 26, 2025
Ondansetron hydrochloride62756-109PowderBulk ingredientsNovember 21, 2025
Clopidogrel bisulfate62756-965PowderBulk ingredientsMarch 31, 2025
Desmopression acetate62756-940PowderBulk ingredientsMarch 31, 2025
Irinotecan hydrochloride trihydrate62756-939PowderBulk ingredientsMarch 31, 2025
Gemcitabine hydrochloride62756-807PowderBulk ingredientsMarch 31, 2025
Nintedanib esylate62756-691PowderBulk ingredientsMarch 31, 2025
Pentetreotide62756-685PowderBulk ingredientsMarch 31, 2025
Pregabalin62756-441PowderBulk ingredientsMarch 31, 2025
Risedronate sodium62756-255PowderBulk ingredientsMarch 31, 2025
Linaclotide62756-154PowderBulk ingredientsMarch 31, 2025
Bivalirudin62756-051PowderBulk ingredientsMarch 31, 2025
Olopatadine hydrochloride62756-041PowderBulk ingredientsMarch 31, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.